Related Experiment Video

Updated: Feb 27, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.9K

Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

Yi Zhou1, Zhigang Ji1, Weigang Yan1

  • 1Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100000, P.R. China.

Oncology Reports
|July 6, 2017
PubMed

Insights

Tetramethylpyrazine (TMP) inhibits prostate cancer cell growth by reducing proliferation, migration, and invasion. This anticancer effect is linked to TMP

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer (PCa) remains a significant health concern, necessitating novel therapeutic strategies.
  • Tetramethylpyrazine (TMP), a compound with known anticancer properties, has not been fully evaluated for its effects on PC-3 prostate cancer cells.
  • The role of FOXM1 in prostate cancer progression warrants further investigation.

Purpose of the Study:

  • To investigate the effects of Tetramethylpyrazine (TMP) on the proliferation, migration, and invasion of prostate cancer (PCa) PC-3 cells.
  • To elucidate the role of FOXM1 in mediating the potential anticancer effects of TMP in PCa.
  • To assess the in vivo efficacy of TMP in a prostate cancer model.

Main Methods:

  • PC-3 cells were treated with varying concentrations of TMP.
  • Cell proliferation, migration, and invasion were assessed using MTT, wound healing, and colony formation assays.
  • FOXM1 expression was analyzed via Western blotting.
  • In vivo studies evaluated TMP's effect on PCa tumor growth.

Main Results:

  • TMP significantly inhibited the proliferation, migration, and invasion of PC-3 cells in a dose-dependent manner.
  • TMP treatment led to a significant downregulation of FOXM1 expression in PC-3 cells.
  • Overexpression of FOXM1 counteracted the inhibitory effects of TMP on PC-3 cell behaviors.
  • TMP demonstrated dose-dependent inhibition of prostate cancer growth in vivo.

Conclusions:

  • Tetramethylpyrazine (TMP) exhibits significant anticancer activity against prostate cancer PC-3 cells.
  • TMP exerts its inhibitory effects by downregulating the expression of FOXM1.
  • TMP holds potential as a therapeutic agent for prostate cancer treatment.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.1K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K